Navigation Links
More Midwest Seed-Stage Life Science VCs

The Dave Clark Five song Bits and Pieces is a good metaphor for the apparently holey (as in Swiss cheese) tapestry of Midwest VC seed and early stage financing efforts to get life science companies off the ground.

This weeks column will try to knit together some of these pieces so the tapestry doesnt fall apart. Last weeks column evoked responses from a number of readers who remarked on ......

Full article >>> in Minneapolis), OpGen (in Madison), TeraMedica (a medical imaging company in Milwaukee) and Deltanoid Pharmaceuticals (in Madison).

Frazier Healthcare Ventures

This California-based VC has set up shop in Madison as a result of having won (along with Baird Venture Partners) the latest round of SWIB Midwest start-up company funding.

By the way, according to the S......

Full article >>> fund is a subsidiary of the Heartland Capital Network, which is a consortium of financing programs for business ventures in the greater Peoria, Ill. region.

The new seed-stage fund, which initially consisted of $2 million, has resulted from the efforts of Peoria community leaders Glen Barton (former president and CEO of Caterpillar, which is headquartered in Peoria) and Doug Stewart, re......

Full article >>> hemical, Ft. Dodge Animal Health, PIC International Group, Seminis Vegetable Seeds, Tyco and the U.S. Department of Agriculture.

Given its location, the main thrust of this organization seems to be in technologies and companies related to the fields of animal sciences, plant science, biocatalysts, materials sciences and instrumentation.

The consortium funds university research ......

Full article >>> blank">EDF in Ann Arbor has about $117 million under management in three funds. It focuses on health care and information technology that has originated in the Midwest.

EDF has assisted 30 companies from the start-up phase with 17 companies based on technology licensed from universities. EDF currently has 13 active investments (of which five are in the health-care space). It initiall......

Full article >>> in St. Louis), Centerre Healthcare (in St. Louis), Velocimed (in Minneapolis) and Kereos (in St. Louis).

While the size of their fund isnt clear, RiverVest is investing in medical devices, biotech, specialty pharma and tools for drug discovery. Investments range from $500,000 to $3 million initially and total investments up to $4 to $6 million per company. From its quarterly newsletter, ......

Full article >>>
'"/>

Source:wistechnology.com By Michael Rosen 08/02/04


Related biology technology :

1. Midwest life science stocks kept sizzling in Q2
2. Midwest life science stocks sizzle in a tepid first quarter
3. A Midwest passage to India, Part II
4. Midwest offers non-stop flight to North Carolina research park
5. A Midwest life-science odyssey comes full circle
6. Midwest hotter for healthcare investments
7. A Midwest small-cap, life-science surprise package
8. 2006: A mixed blessing for Midwest life science companies
9. Midwest gaining stature in nanotech research
10. Midwest colleges strong contenders for NIH funds
11. Japan on the rebound: Implications for Midwest
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers ... 5000 and the 6000i models are higher end machines that use the more unconventional ... spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci has ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)...  The Biodesign Challenge (BDC), a university competition that ... living systems and biotechnology, announced its winning teams at ... New York City . The teams, ... at MoMA,s Celeste Bartos Theater during the daylong summit. ... curator of architecture and design, and Suzanne Lee ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
Breaking Biology Technology:
(Date:5/16/2016)... YORK , May 16, 2016   EyeLock ... solutions, today announced the opening of an IoT Center ... to strengthen and expand the development of embedded iris ... an unprecedented level of convenience and security with unmatched ... authenticate one,s identity aside from DNA. EyeLock,s platform uses ...
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... , April 15, 2016 ... the,  "Global Gait Biometrics Market 2016-2020,"  report to ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait biometrics ... of 13.98% during the period 2016-2020. ... angles, which can be used to compute factors ...
Breaking Biology News(10 mins):